- Guggenheim raised Mongodb Inc (NASDAQ: MDB) price target from $400 to $450. Guggenheim analyst Howard Ma maintained a Buy rating. Mongodb shares closed at $328.87 on Monday. See how other analysts view this stock.
- B of A Securities raised the price target for XPO Inc (NYSE: XPO) from $151 to $158. B of A Securities analyst Ken Hoexter maintained a Buy rating. XPO shares closed at $143.43 on Monday. See how other analysts view this stock.
- JP Morgan raised Formula One Group (NASDAQ: FWONK) price target from $120 to $122. JP Morgan analyst David Karnovsky maintained an Overweight rating. Formula One Group shares closed at $94.80 on Monday. See how other analysts view this stock.
- Keybanc increased the price target for Applied Materials Inc (NASDAQ: AMAT) from $240 to $285. Keybanc analyst Steve Barger maintained an Overweight rating. Applied Materials shares closed at $254.75 on Monday. See how other analysts view this stock.
- B of A Securities boosted the price target for Credo Technology Group Holding Ltd (NASDAQ: CRDO) from $165 to $240. B of A Securities analyst Vivek Arya maintained a Buy rating. Credo Technology shares closed at $171.13 on Monday. See how other analysts view this stock.
- Barclays increased Johnson & Johnson (NYSE: JNJ) price target from $176 to $197. Barclays analyst Matt Miksic maintained an Equal-Weight rating. Johnson & Johnson shares settled at $205.34 on Monday. See how other analysts view this stock.
- Baird raised Albemarle Corp (NYSE: ALB) price target from $81 to $113. Baird analyst Ben Kallo upgraded the stock from Underperform to Neutral. Albemarle shares closed at $128.33 on Monday. See how other analysts view this stock.
- Guggenheim increased Universal Health Services Inc (NYSE: UHS) price target from $253 to $274. Guggenheim analyst Jason Cassorla maintained a Buy rating. Universal Health shares closed at $239.43 on Monday. Â See how other analysts view this stock.
- Cantor Fitzgerald cut the price target for Janux Therapeutics Inc (NASDAQ: JANX) from $200 to $150. Cantor Fitzgerald analyst Josh Schimmer maintained an Overweight rating. Janux Therapeutics shares settled at $33.99 on Monday. See how other analysts view this stock.
- TD Cowen raised Darling Ingredients Inc (NYSE: DAR) price target from $34 to $45. TD Cowen analyst Jason Gabelman upgraded the stock from Hold to Buy. Darling Ingredients shares closed at $36.77 on Monday. See how other analysts view this stock.
- Guggenheim raised **Mongodb Inc** (NASDAQ: MDB) price target from $400 to $450. Guggenheim analyst Howard Ma maintained a Buy rating. Mongodb shares closed at $328.87 on Monday. See how other analysts view this stock.
- B of A Securities raised the price target for **XPO Inc** (NYSE: XPO) from $151 to $158. B of A Securities analyst Ken Hoexter maintained a Buy rating. XPO shares closed at $143.43 on Monday. See how other analysts view this stock.
- JP Morgan raised **Formula One Group** (NASDAQ: FWONK) price target from $120 to $122. JP Morgan analyst David Karnovsky maintained an Overweight rating. Formula One Group shares closed at $94.80 on Monday. See how other analysts view this stock.
- Keybanc increased the price target for **Applied Materials Inc** (NASDAQ: AMAT) from $240 to $285. Keybanc analyst Steve Barger maintained an Overweight rating. Applied Materials shares closed at $254.75 on Monday. See how other analysts view this stock.
- B of A Securities boosted the price target for **Credo Technology Group Holding Ltd** (NASDAQ: CRDO) from $165 to $240. B of A Securities analyst Vivek Arya maintained a Buy rating. Credo Technology shares closed at $171.13 on Monday. See how other analysts view this stock.
- Barclays increased **Johnson & Johnson** (NYSE: JNJ) price target from $176 to $197. Barclays analyst Matt Miksic maintained an Equal-Weight rating. Johnson & Johnson shares settled at $205.34 on Monday. See how other analysts view this stock.
- Baird raised **Albemarle Corp** (NYSE: ALB) price target from $81 to $113. Baird analyst Ben Kallo upgraded the stock from Underperform to Neutral. Albemarle shares closed at $128.33 on Monday. See how other analysts view this stock.
- Guggenheim increased **Universal Health Services Inc** (NYSE: UHS) price target from $253 to $274. Guggenheim analyst Jason Cassorla maintained a Buy rating. Universal Health shares closed at $239.43 on Monday. Â See how other analysts view this stock.
- Cantor Fitzgerald cut the price target for **Janux Therapeutics Inc** (NASDAQ: JANX) from $200 to $150. Cantor Fitzgerald analyst Josh Schimmer maintained an Overweight rating. Janux Therapeutics shares settled at $33.99 on Monday. See how other analysts view this stock.
- TD Cowen raised **Darling Ingredients Inc** (NYSE: DAR) price target from $34 to $45. TD Cowen analyst Jason Gabelman upgraded the stock from Hold to Buy. Darling Ingredients shares closed at $36.77 on Monday. See how other analysts view this stock.
<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul class="wp-block-list">
<li>Guggenheim raised <strong>Mongodb Inc</strong> <a class="ticker-link" data-ticker="MDB" data-exchange="NASDAQ" href="https://www.benzinga.com/quote/MDB" target="_blank" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/MDB">MDB</a>)</a> price target from $400 to $450. Guggenheim analyst Howard Ma maintained a Buy rating. Mongodb shares closed at $328.87 on Monday. <a href="https://www.benzinga.com/quote/MDB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised the price target for <strong>XPO Inc</strong> <a class="ticker-link" data-ticker="XPO" data-exchange="NYSE" href="https://www.benzinga.com/quote/XPO" target="_blank" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/XPO">XPO</a>)</a> from $151 to $158. B of A Securities analyst Ken Hoexter maintained a Buy rating. XPO shares closed at $143.43 on Monday. <a href="https://www.benzinga.com/quote/XPO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised <strong>Formula One Group</strong> <a class="ticker-link" data-ticker="FWONK" data-exchange="NASDAQ" href="https://www.benzinga.com/quote/FWONK" target="_blank" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/FWONK">FWONK</a>)</a> price target from $120 to $122. JP Morgan analyst David Karnovsky maintained an Overweight rating. Formula One Group shares closed at $94.80 on Monday. <a href="https://www.benzinga.com/quote/FWONK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc increased the price target for <strong>Applied Materials Inc</strong> <a class="ticker-link" data-ticker="AMAT" data-exchange="NASDAQ" href="https://www.benzinga.com/quote/AMAT" target="_blank" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/AMAT">AMAT</a>)</a> from $240 to $285. Keybanc analyst Steve Barger maintained an Overweight rating. Applied Materials shares closed at $254.75 on Monday. <a href="https://www.benzinga.com/quote/AMAT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities boosted the price target for <strong>Credo Technology Group Holding Ltd</strong> <a class="ticker-link" data-ticker="CRDO" data-exchange="NASDAQ" href="https://www.benzinga.com/quote/CRDO" target="_blank" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/CRDO">CRDO</a>)</a> from $165 to $240. B of A Securities analyst Vivek Arya maintained a Buy rating. Credo Technology shares closed at $171.13 on Monday. <a href="https://www.benzinga.com/quote/CRDO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays increased <strong>Johnson & Johnson </strong><a class="ticker-link" data-ticker="JNJ" data-exchange="NYSE" href="https://www.benzinga.com/quote/JNJ" target="_blank" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/JNJ">JNJ</a>)</a> price target from $176 to $197. Barclays analyst Matt Miksic maintained an Equal-Weight rating. Johnson & Johnson shares settled at $205.34 on Monday. <a href="https://www.benzinga.com/quote/JNJ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird raised <strong>Albemarle Corp</strong> <a class="ticker-link" data-ticker="ALB" data-exchange="NYSE" href="https://www.benzinga.com/quote/ALB" target="_blank" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ALB">ALB</a>)</a> price target from $81 to $113. Baird analyst Ben Kallo upgraded the stock from Underperform to Neutral. Albemarle shares closed at $128.33 on Monday. <a href="https://www.benzinga.com/quote/ALB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Guggenheim increased <strong>Universal Health Services Inc</strong> <a class="ticker-link" data-ticker="UHS" data-exchange="NYSE" href="https://www.benzinga.com/quote/UHS" target="_blank" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/UHS">UHS</a>)</a> price target from $253 to $274. Guggenheim analyst Jason Cassorla maintained a Buy rating. Universal Health shares closed at $239.43 on Monday. Â <a href="https://www.benzinga.com/quote/UHS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Cantor Fitzgerald cut the price target for <strong>Janux Therapeutics Inc</strong> <a class="ticker-link" data-ticker="JANX" data-exchange="NASDAQ" href="https://www.benzinga.com/quote/JANX" target="_blank" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/JANX">JANX</a>)</a> from $200 to $150. Cantor Fitzgerald analyst Josh Schimmer maintained an Overweight rating. Janux Therapeutics shares settled at $33.99 on Monday. <a href="https://www.benzinga.com/quote/JANX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen raised <strong>Darling Ingredients Inc</strong> <a class="ticker-link" data-ticker="DAR" data-exchange="NYSE" href="https://www.benzinga.com/quote/DAR" target="_blank" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/DAR">DAR</a>)</a> price target from $34 to $45. TD Cowen analyst Jason Gabelman upgraded the stock from Hold to Buy. Darling Ingredients shares closed at $36.77 on Monday. <a href="https://www.benzinga.com/quote/DAR/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
<p>Considering buying AMAT stock? Here’s what analysts think: </p>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/amat/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="568" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02093652/image-3-18-1024x568.png" alt="" class="wp-image-1193137" style="width:625px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02093652/image-3-18-1024x568.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02093652/image-3-18-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02093652/image-3-18-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02093652/image-3-18.png 1148w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<p><strong>Read This Next: </strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/trading-ideas/dividends/25/12/49157371/how-to-earn-500-a-month-from-american-eagle-stock-ahead-of-q3-earnings">How To Earn $500 A Month From American Eagle Stock Ahead Of Q3 Earnings</a></strong></li>
</ul>
<p>Photo via Shutterstock</p>